KR940003937A - 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드 - Google Patents

신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드 Download PDF

Info

Publication number
KR940003937A
KR940003937A KR1019930015521A KR930015521A KR940003937A KR 940003937 A KR940003937 A KR 940003937A KR 1019930015521 A KR1019930015521 A KR 1019930015521A KR 930015521 A KR930015521 A KR 930015521A KR 940003937 A KR940003937 A KR 940003937A
Authority
KR
South Korea
Prior art keywords
enantiomers
quinolylmethoxyphenyl
isobutyl
general formula
cycloalkylacetamide
Prior art date
Application number
KR1019930015521A
Other languages
English (en)
Inventor
라다츠 지그프리트
모어스 클라우스-헬무트
마츠케 미하엘
프루흐트만 로마니스
뮐러-페딩하우스 라이너
하쩰만 아르민
Original Assignee
크누트 샤우에르테, 클라우스 데너
바이엘 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크누트 샤우에르테, 클라우스 데너, 바이엘 악티엔게젤샤프트 filed Critical 크누트 샤우에르테, 클라우스 데너
Publication of KR940003937A publication Critical patent/KR940003937A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

본 발명은 대응하는 라세미산 또는 거울상 이성질체 산을 메탄술폰아미드와 반응시키고, 생성되는 최종 라세미 화합물을 통상적인 방법으로 거울상 이성질체로 분리시킬 수 있는 방법으로 제조될 수 있는 신규한 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드에 관한 것이다. 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드는 리폭시게나아제 억제 작용이 있으므로 이에 연루된 질환의 치료용 의약의 활성 화합물로서 사용될 수 있다.

Description

신규한 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (10)

  1. 하기 일반식의 신규한 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드 및 그의 염.
    상기 식 중, R¹은 시클로헥실, 시클로펜틸 또는 시클로헵틸이며, R1이 시클로헥실인 경우 화합물은 라세메이트 및 거울상 이성질체이고 R¹이 시클로펜틸 또는 시클로헵틸인 경우 화합물은 거울상 이성질체이다.
  2. 하기 일반식의 화합물의 라세메이트, (+)-거울상 이성질체 및 (-)-거울상 이성질체 및 그의 염
  3. 하기 일반식의 화합물의 (+)-거울상 이성질체 및 (-)-거울상 이성질체 및 그의 염.
  4. 하기 일반식의 화합물의 (+)-거울상 이성질체 및 (-)-거울상 이성질체 및 그의 염.
  5. 치료적 용도의 제1항에 따른 신규한 이소부틸-치환 메탄술포닐-퀴놀릴메톡시 페닐-시클로알킬아세트아미드.
  6. 하기 일반식(Ⅱ)의 카르복실산을, 불활성 용매중의 염기 및 (또는) 촉매의 존재하에, 적절한 경우 예비 활성화 과정을 거럭 하기 일반식(Ⅲ)외 메탄술폰아미드와 반응시키고, 목적 물질이 거울상 이성질체인 경우, 직접 순수한 거울상 이성질체 산(Ⅱ)을 사용하거나 또는 라세메이트를 통상의 방법으로 분리하는 것을 특징으로 하는 제1항에 따른 신규한 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드의 제조 방법.
    H2N-SO2-CH3(Ⅲ)
    식 중, R1은 제1항에 정의한 바와 같다.
  7. 제6항에 있어서, 거울상 이성질체를 칼럼 크로마토그래피에 의해 분리하는 것을 특징으로 하는 방법.
  8. 제1항에 따른 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드 1종 이상을 함유하는 의약.
  9. 제1항에 따른 이소부틸-치환 메탄술포닐-퀴놀릴메톡시페닐-시클로알킬아세트아미드의 의약의 제조를 위한 용도.
  10. 제9항에 있어서, 리폭시게나아제-억제 의약의 제조를 위한 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930015521A 1992-08-12 1993-08-11 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드 KR940003937A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4226649A DE4226649A1 (de) 1992-08-12 1992-08-12 Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DEP420260649.1 1992-08-12

Publications (1)

Publication Number Publication Date
KR940003937A true KR940003937A (ko) 1994-03-14

Family

ID=6465373

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930015521A KR940003937A (ko) 1992-08-12 1993-08-11 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드

Country Status (19)

Country Link
EP (1) EP0582916A1 (ko)
JP (1) JPH06157462A (ko)
KR (1) KR940003937A (ko)
CN (1) CN1039998C (ko)
AU (1) AU669913B2 (ko)
CA (1) CA2103600A1 (ko)
CZ (1) CZ282341B6 (ko)
DE (1) DE4226649A1 (ko)
FI (1) FI933529A (ko)
HU (1) HUT70171A (ko)
IL (1) IL106623A0 (ko)
MX (1) MX9304608A (ko)
MY (1) MY108716A (ko)
NO (1) NO179948C (ko)
NZ (1) NZ248350A (ko)
PL (1) PL174102B1 (ko)
RU (1) RU2103261C1 (ko)
SK (1) SK86693A3 (ko)
ZA (1) ZA935828B (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
US5931170A (en) * 1998-10-08 1999-08-03 Addway Engineering Limited Dental flosser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (de) * 1988-04-29 1989-11-09 Bayer Ag (alpha)-substituierte 4-(chinolin-2-yl-methoxy)phenylessigsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3900261A1 (de) * 1988-05-31 1989-12-07 Bayer Ag Substituierte 4-(chinolin-2-yl-methoxy) phenyl-essigsaeure-derivate
DE3916663A1 (de) * 1989-05-23 1990-11-29 Bayer Ag Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren

Also Published As

Publication number Publication date
AU669913B2 (en) 1996-06-27
DE4226649A1 (de) 1994-02-17
IL106623A0 (en) 1993-12-08
NO179948C (no) 1997-01-15
FI933529A0 (fi) 1993-08-10
MX9304608A (es) 1994-02-28
PL174102B1 (pl) 1998-06-30
RU2103261C1 (ru) 1998-01-27
CZ163693A3 (en) 1994-03-16
CA2103600A1 (en) 1994-02-13
NZ248350A (en) 1994-12-22
MY108716A (en) 1996-11-30
SK86693A3 (en) 1994-09-07
FI933529A (fi) 1994-02-13
NO932731D0 (no) 1993-07-29
HU9302320D0 (en) 1993-10-28
CN1087084A (zh) 1994-05-25
NO179948B (no) 1996-10-07
JPH06157462A (ja) 1994-06-03
AU4425593A (en) 1994-02-17
ZA935828B (en) 1994-03-10
EP0582916A1 (de) 1994-02-16
CN1039998C (zh) 1998-09-30
CZ282341B6 (cs) 1997-07-16
HUT70171A (en) 1995-09-28
NO932731L (no) 1994-02-14
PL300025A1 (en) 1994-03-21

Similar Documents

Publication Publication Date Title
AU626740B2 (en) Aminocarbonylcarbamates related to physostigmine, a process for their preparation and their use as medicaments
KR920701177A (ko) 3-아릴옥사졸리디논 유도체, 그의 제조 방법 및 그의 치료 용도
BR8804985A (pt) Processo para recuperar trimetoxissilano a partir de uma mistura de trimetoxissilano e metanol,mistura esta capaz de formar um azeotropo
KR940003937A (ko) 신규한 이소부틸-치환 메탄술포닐 퀴놀릴메톡시페닐-시클로알킬아세트아미드
ES2039272T3 (es) Sales opticamente activas a base de un tiazolidin-4-carboxilato sustituido y 3-cloro-2-hidroxipropiltrimetilamonio, su preparacion y empleo.
KR910002865A (ko) 피라노벤즈옥사디아졸 화합물 및 그 광학적 분할방법
KR880006239A (ko) 기라제 억제제, 그의 제조방법 및 용도
DE3061367D1 (en) Process for the obtention of the enantiomeric forms of 4-cyane-1-(n-methyl-n-(2'-((3",4"-dimethoxyphenyl))ethyl-amino)-5-methyl-4-(3',4',5'-trimethoxyphenyl) hexane and its salts
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
CA1265522C (ko)
KR840004422A (ko) 사이프로헵타딘-3-카복실산의 에스테르 및 관련 화합물의 제조방법
KR840006626A (ko) 케토화합물의 제조방법
FR2366246A1 (fr) Synthese du 3-chloro-1,2-propane-diol-s et produit obtenu
KR840006656A (ko) 1,3,4,6,7,11b-헥사하이드로-7-아릴-2H-피라지노[2,1-α]이소퀴놀린의 제조방법
CA2019717A1 (en) (1,2,3,4-tetrahydro-9-acridinimino)cyclohexane carboxylic acid and related compounds, a process for their preparation and their use as medicaments
KR900011759A (ko) 사이클로 헥산아세트 아미드 유도체
NO923412D0 (no) Fremgangsmaate for enantiomeropploesning av 5-hetaryl-1,3,4-tiadiazinon
KR880011096A (ko) 광학 활성 옥소-이소인돌리닐 유도체
FI875602A0 (fi) Optiskt aktivt tetrahydro-2-furanonderivat saosom miksobicid.
DE69803636T2 (de) Verfahren zur Herstellung von (1S,2R)-1-Amino-2-indanol-(R,R)-tartrate methanol Solvat
ES456466A1 (es) Procedimiento de preparacion de 1-tec-butilamino-3-(2,5-diclorofenoxi-2-propanol) racemico y opticamente activo,y de sus sales de adicion acidas
KR890006626A (ko) 고혈압치료용 벤조피란 유도체
KR920016397A (ko) α-할로알카노익산 라세미 혼합물의 광학분할방법
KR970027075A (ko) 광학이성질체의 분리방법
TH7770EX (th) " กระบวนการสำหรับทำให้ 1,6-เฮกเซนไดโอลบริสุทธิ์ "

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application